Impacts of Metabolic Variation on Neuroendocrine Control of Reproduction

NCT ID: NCT01058681

Last Updated: 2011-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2010-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the potential effects of a changing metabolic environment on GnRH hypothalamic neurons, by performing studies of LH pulsatility (basal and during clamp studies) in different groups of male subjects fed isocaloric and hypercaloric diets. The participation of other gastro-intestinal tract hormones to these regulations will be systematically evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuroendocrine Reproductive Status

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

isocaloric

impacts of isocaloric nutrition on LH pulsatility in euglycemic and hyperinsulinemic clamps

Group Type OTHER

effect of metabolic variations on LH pulsatility

Intervention Type DIETARY_SUPPLEMENT

Isocaloric diet: 1,5 times basal metabolism. Constitution:55% carbohydrates, 15% proteins and 30% fat.

Hypercaloric diet: addition of 30% fat and 3 g of fructose/kg of weight to isocaloric diet.

PO and IV glucose during clamps: PO administration of 90 mg/kg glucose at 90 minutes intervals during the clamp, and adjustment of the IV perfusion to keep euglycemia.

hypercaloric

impacts of hypercaloric nutrition on LH pulsatility in euglycemic and hyperinsulinemic clamps

Group Type OTHER

effect of metabolic variations on LH pulsatility

Intervention Type DIETARY_SUPPLEMENT

Isocaloric diet: 1,5 times basal metabolism. Constitution:55% carbohydrates, 15% proteins and 30% fat.

Hypercaloric diet: addition of 30% fat and 3 g of fructose/kg of weight to isocaloric diet.

PO and IV glucose during clamps: PO administration of 90 mg/kg glucose at 90 minutes intervals during the clamp, and adjustment of the IV perfusion to keep euglycemia.

per os and IV glucose during the clamp

impacts of per os glucose on LH pulsatility in euglycemic and hyperinsulinemic clamps

Group Type OTHER

effect of metabolic variations on LH pulsatility

Intervention Type DIETARY_SUPPLEMENT

Isocaloric diet: 1,5 times basal metabolism. Constitution:55% carbohydrates, 15% proteins and 30% fat.

Hypercaloric diet: addition of 30% fat and 3 g of fructose/kg of weight to isocaloric diet.

PO and IV glucose during clamps: PO administration of 90 mg/kg glucose at 90 minutes intervals during the clamp, and adjustment of the IV perfusion to keep euglycemia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

effect of metabolic variations on LH pulsatility

Isocaloric diet: 1,5 times basal metabolism. Constitution:55% carbohydrates, 15% proteins and 30% fat.

Hypercaloric diet: addition of 30% fat and 3 g of fructose/kg of weight to isocaloric diet.

PO and IV glucose during clamps: PO administration of 90 mg/kg glucose at 90 minutes intervals during the clamp, and adjustment of the IV perfusion to keep euglycemia.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male
* age between 18 and 25 years old
* no known pathology
* normal physical exam
* BMI between 20 and 25 kg/m2

Exclusion Criteria

* history of endocrine disease
* no known infertility (no conception after 12 months of regular unprotected intercourse)
* abnormal results on the initial blood tests (CBC, fasting glucose and insulin, HbA1C, TSH, free T4, LH, FSH, inhibin B and total testosterone)
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

CHUV

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François Pralong

Role: PRINCIPAL_INVESTIGATOR

CHUV

Vittorio Giusti

Role: STUDY_DIRECTOR

CHUV

Luc Tappy

Role: STUDY_DIRECTOR

CHUV

Marie-Hélène Pesant

Role: STUDY_DIRECTOR

CHUV

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHUVaudois

Lausanne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Pesant MH, Dwyer A, Marques Vidal P, Schneiter P, Giusti V, Tappy L, Pralong FP. The lack of effect of insulin on luteinizing hormone pulsatility in healthy male volunteers provides evidence of a sexual dimorphism in the metabolic regulation of reproductive hormones. Am J Clin Nutr. 2012 Aug;96(2):283-8. doi: 10.3945/ajcn.111.030189. Epub 2012 Jul 3.

Reference Type DERIVED
PMID: 22760567 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Grant number 320030-124886

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

Swiss national science fund

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neuropeptides in Human Reproduction
NCT01952782 COMPLETED PHASE1